<DOC>
	<DOC>NCT00833027</DOC>
	<brief_summary>Canadian physicians to experience in real life clinical practice the efficacy and tolerability of adding sitagliptin to their patients who have their glycemic levels inadequately controlled while on metformin</brief_summary>
	<brief_title>ALPHA Sitagliptin Add on to Metformin (0431-103)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient Is Currently On Monotherapy With Metformin For At Least 10 Weeks Prior To Study Entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>